Exact Mass: 614.1242

Exact Mass Matches: 614.1242

Found 14 metabolites which its exact mass value is equals to given mass value 614.1242, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

2-Cinnamoyl-1,6-digalloyl-beta-D-glucopyranose

(3,4-Dihydroxy-5-{[(2Z)-3-phenylprop-2-enoyl]oxy}-6-(3,4,5-trihydroxybenzoyloxy)oxan-2-yl)methyl 3,4,5-trihydroxybenzoic acid

C29H26O15 (614.1272)


2-Cinnamoyl-1,6-digalloyl-beta-D-glucopyranose is found in green vegetables. 2-Cinnamoyl-1,6-digalloyl-beta-D-glucopyranose is isolated from commercial rhubarbs (Rheum sp.). Isolated from commercial rhubarbs (Rheum species). 2-Cinnamoyl-1,6-digalloyl-beta-D-glucopyranose is found in green vegetables.

   

6-Cinnamoyl-1,2-digalloylglucose

4,5-Dihydroxy-6-({[(2E)-3-phenylprop-2-enoyl]oxy}methyl)-2-(3,4,5-trihydroxybenzoyloxy)oxan-3-yl 3,4,5-trihydroxybenzoic acid

C29H26O15 (614.1272)


6-Cinnamoyl-1,2-digalloylglucose is found in green vegetables. 6-Cinnamoyl-1,2-digalloylglucose is isolated from commercial rhubarbs (Rheum species). Isolated from commercial rhubarbs (Rheum subspecies). 6-Cinnamoyl-1,2-digalloylglucose is found in green vegetables.

   

Fosaprepitant

(3-{[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl}-5-oxo-2,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonic acid

C23H22F7N4O6P (614.1165)


Fosaprepitant is only found in individuals that have used or taken this drug. It is an intravenously administered antiemetic drug. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment.Aprepitant has been shown in animal models to inhibit emesis induced by cytotoxic chemotherapeutic agents, such as cisplatin, via central actions. Animal and human Positron Emission Tomography (PET) studies with Aprepitant have shown that it crosses the blood brain barrier and occupies brain NK1 receptors. Animal and human studies show that Aprepitant augments the antiemetic activity of the 5-HT3-receptor antagonist ondansetron and the corticosteroid ethasone and inhibits both the acute and delayed phases of cisplatin induced emesis.In summary, the active form of fosaprepitant is as an NK1 antagonist which is because it blocks signals given off by NK1 receptors. This therefore decreases the likelihood of vomiting in patients experiencing. D018377 - Neurotransmitter Agents > D064729 - Neurokinin-1 Receptor Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents

   
   

beta-D-Pyranose-6-Cinnamoyl-1, 2-digalloylglucose

beta-D-Pyranose-6-Cinnamoyl-1, 2-digalloylglucose

C29H26O15 (614.1272)


   

3-methoxy-7-O-beta-(6-galloylglucopyranoside)quercetin

3-methoxy-7-O-beta-(6-galloylglucopyranoside)quercetin

C29H26O15 (614.1272)


   

Fosaprepitant

(3-{[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl}-5-oxo-2,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonic acid

C23H22F7N4O6P (614.1165)


D018377 - Neurotransmitter Agents > D064729 - Neurokinin-1 Receptor Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents

   

2-Cinnamoyl-1,6-digalloyl-beta-D-glucopyranose

4,5-dihydroxy-3-{[(2Z)-3-phenylprop-2-enoyl]oxy}-6-{[(3,4,5-trihydroxyphenyl)carbonyloxy]methyl}oxan-2-yl 3,4,5-trihydroxybenzoate

C29H26O15 (614.1272)


   

6-Cinnamoyl-1,2-digalloylglucose

4,5-dihydroxy-6-({[(2E)-3-phenylprop-2-enoyl]oxy}methyl)-3-[(3,4,5-trihydroxyphenyl)carbonyloxy]oxan-2-yl 3,4,5-trihydroxybenzoate

C29H26O15 (614.1272)


   

1,6-digalloyl-2-cinnamoyl-glucose

1-O,6-O-Digalloyl-2-O-cinnamoyl-beta-D-glucopyranose; [(2R,3S,4S,5R,6S)-3,4-dihydroxy-5-[(E)-3-phenylprop-2-enoyl]oxy-6-(3,4,5-trihydroxybenzoyl)oxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate; AC1O3D78

C29H26O15 (614.1272)


{"Ingredient_id": "HBIN001857","Ingredient_name": "1,6-digalloyl-2-cinnamoyl-glucose","Alias": "1-O,6-O-Digalloyl-2-O-cinnamoyl-beta-D-glucopyranose; [(2R,3S,4S,5R,6S)-3,4-dihydroxy-5-[(E)-3-phenylprop-2-enoyl]oxy-6-(3,4,5-trihydroxybenzoyl)oxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate; AC1O3D78","Ingredient_formula": "C29H26O15","Ingredient_Smile": "C1=CC=C(C=C1)C=CC(=O)OC2C(C(C(OC2OC(=O)C3=CC(=C(C(=C3)O)O)O)COC(=O)C4=CC(=C(C(=C4)O)O)O)O)O","Ingredient_weight": "614.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15054","TCMID_id": "5513","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "6325082","DrugBank_id": "NA"}

   

11-bromo-15-(2-bromopropan-2-yl)-12,21-dihydroxy-4-methoxy-4,8,12-trimethyl-16-oxatetracyclo[16.3.1.0³,⁸.0⁵,⁷]docosa-1(22),18,20-trien-17-one

11-bromo-15-(2-bromopropan-2-yl)-12,21-dihydroxy-4-methoxy-4,8,12-trimethyl-16-oxatetracyclo[16.3.1.0³,⁸.0⁵,⁷]docosa-1(22),18,20-trien-17-one

C28H40Br2O5 (614.1242)


   

(3s,4r,8r,11r,12s,15s)-11-bromo-15-(2-bromopropan-2-yl)-12,21-dihydroxy-4-methoxy-4,8,12-trimethyl-16-oxatetracyclo[16.3.1.0³,⁸.0⁵,⁷]docosa-1(22),18,20-trien-17-one

(3s,4r,8r,11r,12s,15s)-11-bromo-15-(2-bromopropan-2-yl)-12,21-dihydroxy-4-methoxy-4,8,12-trimethyl-16-oxatetracyclo[16.3.1.0³,⁸.0⁵,⁷]docosa-1(22),18,20-trien-17-one

C28H40Br2O5 (614.1242)


   

(3s,8r,11r,12s,15s)-11-bromo-15-(2-bromopropan-2-yl)-12,21-dihydroxy-4-methoxy-4,8,12-trimethyl-16-oxatetracyclo[16.3.1.0³,⁸.0⁵,⁷]docosa-1(22),18,20-trien-17-one

(3s,8r,11r,12s,15s)-11-bromo-15-(2-bromopropan-2-yl)-12,21-dihydroxy-4-methoxy-4,8,12-trimethyl-16-oxatetracyclo[16.3.1.0³,⁸.0⁵,⁷]docosa-1(22),18,20-trien-17-one

C28H40Br2O5 (614.1242)


   

(3s,4r,5r,7s,8r,11r,12s,15s)-11-bromo-15-(2-bromopropan-2-yl)-12,21-dihydroxy-4-methoxy-4,8,12-trimethyl-16-oxatetracyclo[16.3.1.0³,⁸.0⁵,⁷]docosa-1(22),18,20-trien-17-one

(3s,4r,5r,7s,8r,11r,12s,15s)-11-bromo-15-(2-bromopropan-2-yl)-12,21-dihydroxy-4-methoxy-4,8,12-trimethyl-16-oxatetracyclo[16.3.1.0³,⁸.0⁵,⁷]docosa-1(22),18,20-trien-17-one

C28H40Br2O5 (614.1242)